| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2170981 | Cytokine & Growth Factor Reviews | 2006 | 9 Pages |
Abstract
Smad3, a key mediator for TGF-β antiproliferative responses, is phosphorylated by both CDK4 and CDK2 in vivo and in vitro. Except for the Rb family members, Smad3 is the only CDK4 substrate demonstrated so far. CDK phosphorylation of Smad3 inhibits its transcriptional activity and antiproliferative function. Because cancer cells often contain high levels of CDK activity, inhibition of Smad activity by CDK phosphorylation may contribute to tumorigenesis and TGF-β resistance in cancers.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
Fang Liu,